Presentation TCT 2014 TAVR Is Preferred for All but the Lowest-Risk Patients! Presenter: Alejandro O. Palacios, Ernesto M. Torresani, Alec S. Vahanian September 13, 2014
Presentation TCT 2014 Surgery for All but the Highest-Risk Patients! Presenter: Alejandro O. Palacios, Ernesto M. Torresani, Jose Navia September 13, 2014
Presentation TCT 2014 TCT 689: Three- and Five-Year Outcomes after Transcatheter Aortic Valve Implantation in High-Risk Patients with Severe Aortic Stenosis: The U.K. TAVI (United Kingdom Aortic Valve Implantation) Registry Presenter: Patrick W. Serruys, E. Murat Tuzcu, Ian T. Meredith, Alison Duncan September 13, 2014
Presentation TCT 2014 Thoughtful Perspectives on the Futile Patient with Aortic Stenosis Presenter: Martin B. Leon, Neil E. Moat, Ariel Finkelstein, Robert A. Guyton September 13, 2014
Presentation TCT 2014 Important Changes in the New 2014 ACC/AHA Aortic Valve Guidelines: Aligning Definitions of Aortic Stenosis Severity with Treatment Recommendations Presenter: A. Pieter Kappetein, Martin B. Leon, Howard C. Herrmann, Robert O. Bonow September 13, 2014
Presentation TCT 2014 The CoreValve US Pivotal Trial: Two-Year Results with a Self-Expanding Bioprosthesis in Extremely High-Risk Patients with Aortic Stenosis Presenter: Robert J. Applegate, Ronald Caputo, Steven J. Yakubov September 13, 2014
Presentation TCT 2014 CLEAN-TAVI: A Prospective, Randomized Trial of Cerebral Embolic Protection in High-Risk Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement Presenter: Patrick W. Serruys, David J. Cohen, Axel Linke September 13, 2014
Presentation TCT 2014 US CoreValve High Risk Trial: Cost-Effectiveness Analysis From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Self-Expanding Device Versus Surgical Aortic Valve Replacement in High-Risk Patients with Aortic Stenosis Presenter: Patrick W. Serruys, David J. Cohen, Matthew R. Reynolds September 13, 2014
Presentation TCT 2014 PARTNER I: Five-Year Results From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Balloon-Expandable Device Versus Conservative Care in Extremely High-Risk Patients with Aortic Stenosis Presenter: Patrick W. Serruys, David J. Cohen, Samir R. Kapadia September 13, 2014
Presentation TCT 2014 Hemodynamics of Aortic Stenosis and Live Calculations Using the Telestrator Presenter: Thomas H. Maloney, John R. Zimmerman, Tim J. Lapp September 13, 2014
Presentation ESC 2014 Is TAVR the treatment of choice for high risk diabetic patients with aortic stenosis? Insights from the FRANCE2 Registry Presenter: Eric Van Belle September 02, 2014
Presentation Predictors of Permanent Pacemaker in Patients with Severe Aortic Stenosis Undergoing TAVR Presenter: G.C.M. Siontis July 08, 2014
Presentation TVT 2014 TAVI in A Bicuspid Aortic Valve Stenosis With Edwards Sapien 3 In A Thrilling Scenario Presenter: Caterina Gandolfo June 06, 2014
Presentation TVT 2014 2014 ACC/AHA Aortic Valve Guidelines: Aligning Definitions of Aortic Stenosis Severity with Treatment Recommendations Presenter: Catherine M. Otto June 05, 2014
Presentation ECHO 2014 Cases: Low-Flow, Low-Gradient Aortic Stenosis Presenter: Philippe Pibarot April 09, 2014
Presentation ECHO 2014 Aortic Stenosis Quantitation: Old and New Methods of Assessment Presenter: Philippe Pibarot April 09, 2014
Presentation TAVR Using a Self-expanding Bioprosthesis in Patients with Severe Aortic Stenosis at Extreme Risk for Surgery Presenter: Jeffrey J. Popma March 19, 2014
Presentation Prognostic Implications of Pulmonary Hypertension in Pts with Severe Aortic Stenosis Undergoing TAVR Presenter: Adrien Lu?on March 06, 2014
Presentation Sex-Related Differences After TAVR or SAVR in Patients with Severe Aortic Stenosis Presenter: M. Williams February 18, 2014
Presentation Overcoming Diagnostic Challenges in Aortic Stenosis: Evaluations for TAVR Presenter: David S. Rubenson February 05, 2014